BIOMAT Database Logo BIOMAT Database Logo

Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol. 2022

Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
Diabetes Center, Ebina General Hospital.

OBJECTIVE Abnormal compositional changes in low-density lipoprotein (LDL) particles, such as triglyceride (TG) enrichment and size reduction, are common in patients with diabetes. Several cohort studies have demonstrated that LDL-TG and sdLDL-cholesterol (C) are sensitive biomarkers for predicting atherosclerotic cardiovascular diseases beyond LDL-C. Although sdLDL has been extensively studied, little is known about the properties of LDL-TG. We investigated similarities or differences between LDL-TG and sdLDL-C. METHODS Fasting plasma was obtained from 1,085 patients with type 2 diabetes who were enrolled in the diabetes regional cohort study (ViNA Cohort). LDL-TG and sdLDL-C concentrations were measured using a homogeneous assay established by us. In a subset of subjects, LDL-TG and sdLDL-C levels were measured postprandially or after treatment with lipid-lowering drugs. RESULTS In a quartile analysis, higher LDL-TG quartiles were associated with higher frequency of female and fibrate users, whereas sdLDL-C quartiles were associated with frequency of men, drinking, and metabolic syndrome-related measurements. Higher quartiles of LDL-TG/LDL-C were associated with smoking, drinking, fibrate users, and statin users. LDL-TG was significantly correlated with TG, LDL-C, sdLDL-C, and apolipoprotein (apo) B, with apoB being the primary determinant. LDL-TG correlated to high sensitive C-reactive protein (CRP) independently of other lipids. Mean LDL-TG did not change with fasting/non-fasting. Statin treatment reduced LDL-TG, whereas fibrates increased it, but these drugs reduced sdLDL-C equally. CONCLUSIONS LDL-TG levels were more tightly regulated by the number of LDL particles than plasma TG levels were. SdLDL-C was closely associated with metabolic syndrome-related factors, whereas LDL-TG was associated with low-grade systemic inflammation.

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
[Clinical significance of small, dense LDL cholesterol in patients with hyperlipidemia and type 2 diabetes].
August 2007, Rinsho byori. The Japanese journal of clinical pathology,
Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.
January 2017, Cardiovascular diabetology,
Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.
November 2017, Cardiovascular diabetology,
Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study.
February 2021, Lipids in health and disease,
Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
Triglyceride/low-density-lipoprotein cholesterol ratio is the most valuable predictor for increased small, dense LDL in type 2 diabetes patients.
January 2022, Lipids in health and disease,
Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
[Metabolic syndrome and small dense LDL-cholesterol].
May 2007, Rinsho byori. The Japanese journal of clinical pathology,
Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus.
December 2016, Journal of clinical & translational endocrinology,
Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
The effects of statin and fibrate on lowering small dense LDL- cholesterol in hyperlipidemic patients with type 2 diabetes.
June 2007, Journal of atherosclerosis and thrombosis,
Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.
July 1999, Diabetes care,
Tsutomu Hirano, and Rieko Kodera, and Takeshi Hirashima, and Natsuko Suzuki, and Ema Aoki, and Mitsuru Hosoya, and Taito Oshima, and Toshiyuki Hayashi, and Shinji Koba, and Motoko Ohta, and Noriyuki Satoh, and Yasuki Ito
Higher levels of small dense low-density lipoprotein (LDL) are associated with cardiac autonomic neuropathy in patients with type 2 diabetes.
June 2013, Diabetic medicine : a journal of the British Diabetic Association,
Copied contents to your clipboard!